Syneos Health, Inc. (SYNH) Prices 7M Secondary Offering at $59.75/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
After-Hours Movers 09/15: (AXGN) (AMCX) (FDX) Higher; (NKLA) (SYNH) Lower (more...)
September 15, 2020 5:26 PM EDTToday's After-Hours Movers
AxoGen (NASDAQ: AXGN) 20.9% HIGHER; Sees Q3 Revenue of 'At Least' $30M, Versus Consensus of $23M
MC Networks Inc. (NASDAQ: AMCX) 16.3% HIGHER; announced that on September 16, 2020 it plans to commence a modified Dutch auction tender offer to purchase up to $250 million in value of its outstanding Class A common stock, par value $0.01 per share (the Class A Shares), at a price per Class A Share of not less than $22.50 and not greater than $26.50.... More
Syneos Health, Inc. (SYNH) Announces 7M Share Secondary Offering of Common Stock
September 15, 2020 4:51 PM EDTSyneos Health, Inc. (Nasdaq: SYNH) (the Company or Syneos Health), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced it commenced an underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International... More
